ROMANI, Luigina
 Distribuzione geografica
Continente #
NA - Nord America 11.140
EU - Europa 9.486
AS - Asia 2.250
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 20
SA - Sud America 16
OC - Oceania 7
Totale 22.951
Nazione #
US - Stati Uniti d'America 11.113
UA - Ucraina 2.645
IE - Irlanda 2.135
IT - Italia 1.215
SE - Svezia 1.074
HK - Hong Kong 1.025
VN - Vietnam 600
DE - Germania 586
FI - Finlandia 549
RU - Federazione Russa 451
CN - Cina 342
GB - Regno Unito 204
FR - Francia 138
TR - Turchia 137
AT - Austria 113
RO - Romania 90
CH - Svizzera 88
BE - Belgio 56
NL - Olanda 41
PL - Polonia 41
UZ - Uzbekistan 39
CI - Costa d'Avorio 29
GR - Grecia 28
JP - Giappone 28
LB - Libano 26
CA - Canada 25
KR - Corea 21
EU - Europa 19
SG - Singapore 10
BR - Brasile 9
CZ - Repubblica Ceca 8
ID - Indonesia 6
BG - Bulgaria 5
CO - Colombia 4
IN - India 4
NZ - Nuova Zelanda 4
AU - Australia 3
HR - Croazia 3
SK - Slovacchia (Repubblica Slovacca) 3
CL - Cile 2
IR - Iran 2
NO - Norvegia 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
ES - Italia 1
IL - Israele 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MK - Macedonia 1
MX - Messico 1
NG - Nigeria 1
PE - Perù 1
SC - Seychelles 1
SV - El Salvador 1
Totale 22.951
Città #
Chandler 2.299
Dublin 2.128
San Mateo 1.379
Jacksonville 1.362
Hong Kong 1.023
Dong Ket 599
Medford 574
Princeton 568
Perugia 449
Wilmington 430
Ann Arbor 418
Altamura 414
Andover 354
Lawrence 304
Des Moines 273
Beijing 196
Ashburn 154
Saint Petersburg 146
Falls Church 132
Izmir 130
Norwalk 115
Boardman 114
Dearborn 106
Bucharest 71
Vienna 68
Helsinki 60
Los Angeles 60
Brussels 54
San Paolo di Civitate 53
Woodbridge 50
Moscow 40
Redmond 38
Redwood City 31
Abidjan 29
Den Haag 28
Houston 19
Hefei 17
New York 17
Auburn Hills 16
Chicago 16
Guangzhou 16
Rome 16
Fremont 15
Lausanne 15
Ottawa 15
San Diego 14
Seoul 14
Timisoara 14
Nanchang 11
Frankfurt Am Main 10
Milan 10
Nanning 10
Paris 10
Edinburgh 9
Kunming 9
Shenzhen 9
Tappahannock 9
Tokyo 9
Hanover 7
Kocaeli 7
Lappeenranta 7
Nanjing 7
Radomsko 7
Shanghai 7
Cambridge 6
Kiev 6
Philadelphia 6
Renton 6
Torrile 6
Udine 6
Verona 6
Amsterdam 5
Cardiff 5
Dorsten 5
Esslingen am Neckar 5
Fuzhou 5
Liphook 5
Monmouth Junction 5
Simi Valley 5
Collazzone 4
Como 4
Dervio 4
Hangzhou 4
Monreale 4
Pioltello 4
Turin 4
Atlanta 3
Bologna 3
Bratislava 3
Chengdu 3
Durham 3
Falkenstein 3
Florence 3
Groningen 3
Jinan 3
Kraków 3
Ludwigshafen 3
Marina Julia 3
Medellín 3
Naples 3
Totale 14.743
Nome #
A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression. 116
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 114
Indole-3-aldehyde (IAld): a new potential drug for infectious and inflammatory diseases 109
Autophagy and LAP in the Fight against Fungal Infections: Regulation and Therapeutics 103
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 102
Antifungal Th Immunity: Growing up in Family 98
Anti-Candida resistance in the mouse brain and effect of intracerebral administration of interleukin 1. 91
Host Response Signatures to Invasive Aspergillosis 90
Increase of natural killer activity of mouse lymphocytes following in vitro and in vivo treatment with lithium. 86
Adaptive immunity to Aspergillus 85
IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut 85
Cytokine- and T helper-dependent immunity in murine aspergillosis. 83
Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. 80
T helper 2 antagonists restore antifungal T helper immunity in mice with T cell-depleted bone marrow transplantation 79
Dectin-1 isoforms contribute to distinct Th1/Th17 cell activation in mucosal candidiasis. 78
Pathogenic NLRP3 Inflammasome Activity during Candida Infection Is Negatively Regulated by IL-22 via Activation of NLRC4 and IL-1Ra 78
Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. 77
A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis 77
Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals. 75
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 75
Immune regulation and tolerance to fungi in the lungs and skin. 73
Antigen-specific cytolysis of infected cells in murine candidiasis. 73
RATIONALE FOR CYTOKINE AND ANTI-CYTOKINE THERAPY OF CANDIDA-ALBICANS INFECTION 73
IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance 73
Fine-tuning of Th17 Cytokines in Periodontal Disease by IL-10 71
Use of indole-3-aldehyde for treating dysreactive immune disorders 71
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 71
Aspergillus fumigatus tryptophan metabolic route differently affects host immunity 71
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines 70
Cellular proteostasis: a new twist in the action of thymosin α1 70
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. 69
Dynamics of extracellular release of Aspergillus fumigatus DNA and galactomannan during growth in blood and serum. 68
Treatment of aspergillus infections with alpha thymosin peptides 68
NEDD4 controls the expression of GUCD1, a protein upregulated in proliferating liver cells. 68
Cell-mediated immunity to chemically xenogenized tumors--IV. Production of lymphokine activity by, and in response to, highly immunogenic cells. 66
Adoptive immunotherapy of intracerebral murine lymphomas: role of different lymphoid populations. 66
Innate immunity against fungal pathogens. 64
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 64
Sensing Danger Signals and Pathogen-Associated-Molecular Patterns defines binary signalling pathways in mammalian response to fungi Cellular and Cytokine Interactions in Health and Disease 64
The use of N-acetylcisteine as an immunomodulator in vivo and in vitro models of microbial infection 64
Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1-deficient mice. 64
Distinct and complementary roles for Aspergillus fumigatus-specific Tr1 and Foxp3+ regulatory T cells in humans and mice. 64
B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. 63
The interaction pattern of murine serum ficolin-a with microorganisms. 63
null 63
Reply to ‘F508del-CFTR is not corrected by thymosin α1’ 63
Initiation of T-helper cell immunity to Candida albicans by IL-12: the role of neutrophils. 62
The long pentraxin PTX3 as a link between innate immunity, inflammation and female fertility. 62
Antifungal type I responses are upregulated in IL-10-deficient mice. 62
Immunology of Aspergillus and Aspergillosis: The story so far 62
The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation 62
Activation of dendritic cells programs by fungi: implication for Th1/Th2 and regulatory responses. 62
Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. 62
Learning from other diseases: protection and pathology in chronic fungal infections 62
Noncanonical Fungal Autophagy Inhibits Inflammation in Response to IFN-γ via DAPK1. 62
Towards Targeting the Aryl Hydrocarbon Receptor in Cystic Fibrosis 62
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 61
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 61
Biological role of Th cell subsets in candidiasis. 60
Advances in under standing of the pathogenesis of opportunistic fungal diseases: Aspergillosis 60
Sensing of mammalian IL-17A regulates fungal adaptation and virulence. 60
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 60
An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis. 59
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients 59
Cell-mediated immunity to chemically xenogenized tumors. V. Failure of novel antigens to increase the frequency of tumor-specific cytotoxic T cells. 59
Appearance of strong transplantation antigens in non-immunogenic lymphoma following drug-treatment in vivo. 59
Antigenic changes related to drug action. 59
Susceptibility of murine lymphoma cells treated with 5-(3,3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide to NK-mediated cytotoxicity in vitro. 59
In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivo. 59
The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism 59
Neutrophils and the adaptive immune response to Candida albicans. 58
Immune sensing of aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination. 58
A crucial role for tryptophan catabolism at the host/Candida albicans interface. 58
Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. 58
Antifungal immune reactivity in nasal polyposis. 58
Lectin-carbohydrate interactions during Aspergillus/DC cross-talk 58
Host defense pathways against fungi: the basis for vaccines and immunotherapy. 58
Antilymphoma graft responses in the mouse brain: a study of T-dependent functions. 58
Aspergillus fumigatus morphology and dynamic host interactions 58
Adaptation of Candida albicans to the host environment: the role of morphogenesis in virulence and survival in mammalian hosts 58
Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. 57
Aspergillus and innate immunity: Infektiologischen/immunologischen Kolloquium 57
IL-22 and IDO1 Affect Immunity and Tolerance to Murine and Human Vaginal Candidiasis 57
THE MICROBIAL LANDSCAPE OF HEMATOLOGICAL PATIENTS AT RISK FOR ASPERGILLOSIS 57
The Potential Role of Toll-Like Receptor 4 in Mediating Dopaminergic Cell Loss and Alpha-Synuclein Expression in the Acute MPTP Mouse Model of Parkinson's Disease 57
The circadian protein PER1 modulates the cellular response to anticancer treatments 57
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 56
A braking circuit between pathogen- and danger-sensing signaling pathways restrains lung inflammation: role of S100B protein, RAGE and Toll-like receptors. 56
Intrasplenic immunization for the induction of humoral and cell-mediated immunity to nitrocellulose-bound antigen. 56
Antigenic properties of lymphoma sublines derived from a drug-treated immunogenic L5178Y leukemia. 56
Microencapsulation of microbial derived indoles by spray drying 56
Microbes in the Era of Circadian Medicine 56
Mechanisms of cell-mediated immunity in fungal infection. 55
Immunity to Aspergillus fumigatus: the bases for immunotherapy and vaccination. 55
Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-alpha double-deficient mice infected with Candida albicans. 55
Immunoterapia delle infezioni fungine: principi e prospettive nel paziente sottoposto a trapianto 55
Drug-induced immunogenic changes of murine leukemia cells: dissociation of onset of resistance and emergence of novel immunogenicity. 55
ANTI-CYTOKINE THERAPY OF MURINE CANDIDIASIS 55
Innate and adaptive immunity in Candida albicans infections and saprophytism. 54
Acquired Immunity: Fungal Infections 54
Totale 6.688
Categoria #
all - tutte 86.318
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.318


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019177 0 0 0 0 0 0 0 0 0 0 167 10
2019/20202.397 30 15 392 20 402 107 507 49 490 179 45 161
2020/20214.753 23 437 110 418 1.476 182 392 26 506 125 406 652
2021/20224.729 94 930 115 220 219 88 74 1.545 85 105 516 738
2022/20237.662 609 1.142 98 614 705 933 18 384 2.787 23 252 97
2023/20242.117 202 364 143 57 42 27 632 82 460 108 0 0
Totale 24.070